Featured Research

from universities, journals, and other organizations

Growth Factor Receptor Signaling Critical To Intestinal Tumor Development, Studies Show

Date:
January 30, 2002
Source:
University Of North Carolina At Chapel Hill
Summary:
Scientists at the University of North Carolina at Chapel Hill and Vanderbilt University say they have uncovered a major clue to what causes and promotes development of intestinal tumors.

CHAPEL HILL – Scientists at the University of North Carolina at Chapel Hill and Vanderbilt University say they have uncovered a major clue to what causes and promotes development of intestinal tumors.

Working with laboratory mice, the researchers found that a molecule called epidermal growth factor receptor (Egfr) is necessary for most intestinal tumors to form. Their work also suggests that a drug or genetic manipulation that inhibits the receptor’s chemical signaling machinery should help treat advanced colorectal cancers in humans one day.

A report on the findings appears online today (Jan. 29) in the latest edition of the Proceedings of the National Academy of Sciences. Authors include doctoral student Reade B. Roberts and Dr. David W. Threadgill, assistant professor of genetics, both at the UNC School of Medicine’s Lineberger Comprehensive Cancer Center, and Dr. Robert J. Coffey, a cell biologist at Vanderbilt.

“This Egfr receptor is very important to all kinds of tissues and organs, but there hasn’t been any genetic proof in whole animals that it could affect a major cancer like colon cancer,” Reade said. “We think this work represents proof because it relied on genetic experiments that were highly controlled compared with just injecting mice with drugs and hoping that they would affect the receptor.”

At UNC, the researchers studied two kinds of mice. They engineered one set to include a mutation called Apc-Min, which produces both human and mouse intestinal cancers, and another mutation known as waved 2, in which the Egfr was partially impaired. The other mice, litter mates of the first group, bore the same Apc-Min mutation, but also had normal Egfr genes.

Within three months, the first group developed 90 percent fewer intestinal polyps than the second, which showed that Egfr signaling was critical to intestinal tumor formation, scientists found. Some of the first group developed no tumors at all.

“Surprisingly the size, growth and progression of the polyps appeared to be independent of Egfr, and so a small percentage of tumors might not need Egfr to grow,” Roberts said. “Microscopic examination of intestinal tissue in the youngest mice also revealed no differences in the number of lesions believed to be precursors of larger intestinal polyps and cancer. Most just failed to progress.”

Humans who inherit a bad copy of the Apc-Min gene can develop hundreds of tumors throughout their intestinal tracts, he said. That illness, however, represents only about 1 percent of human colon cancer cases.

Mice with the waved 2 mutation have wavy hair and curly whiskers but are otherwise healthy and lead essentially normal lives, Roberts said. Rodents with entirely dysfunctional Egfr die within two weeks of birth, which shows the gene is essential for life.

Related work conducted in Coffey’s laboratory at Vanderbilt involved placing human tumors in mice and then treating the mice with Egfr tyrosine kinase inhibitors -- compounds that block the action of an Egfr signaling enzyme.

“They saw a drastic reduction in tumor growth, depending on the dose they gave the mice,” Roberts said. “That showed the approach definitely holds promise for using these drugs to treat human cancers.

“How well our results in mice wind up correlating with human treatment remains to be seen, but at this point we’re excited about the possibilities.”

Several clinical trials of drugs that block Egfr already have begun, Roberts said. Results from two previous mouse studies of compounds targeting the molecule have been contradictory, probably because drugs used were not precise enough in their action.

Grants from the National Cancer Institute supported the UNC and Vanderbilt research.


Story Source:

The above story is based on materials provided by University Of North Carolina At Chapel Hill. Note: Materials may be edited for content and length.


Cite This Page:

University Of North Carolina At Chapel Hill. "Growth Factor Receptor Signaling Critical To Intestinal Tumor Development, Studies Show." ScienceDaily. ScienceDaily, 30 January 2002. <www.sciencedaily.com/releases/2002/01/020130073603.htm>.
University Of North Carolina At Chapel Hill. (2002, January 30). Growth Factor Receptor Signaling Critical To Intestinal Tumor Development, Studies Show. ScienceDaily. Retrieved September 23, 2014 from www.sciencedaily.com/releases/2002/01/020130073603.htm
University Of North Carolina At Chapel Hill. "Growth Factor Receptor Signaling Critical To Intestinal Tumor Development, Studies Show." ScienceDaily. www.sciencedaily.com/releases/2002/01/020130073603.htm (accessed September 23, 2014).

Share This



More Health & Medicine News

Tuesday, September 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Liberia Pleads for Help to Fight Ebola

Liberia Pleads for Help to Fight Ebola

AP (Sep. 22, 2014) Liberia's finance minister is urging the international community to quickly follow through on pledges of cash to battle Ebola. Bodies are piling up in the capital Monrovia as the nation awaits more help. (Sept. 22) Video provided by AP
Powered by NewsLook.com
Ebola Doctor Says Border Controls Critical

Ebola Doctor Says Border Controls Critical

AP (Sep. 22, 2014) A Florida doctor who helped fight the expanding Ebola outbreak in West Africa says the disease can be stopped, but only if nations quickly step up their response and make border control a priority. (Sept. 22) Video provided by AP
Powered by NewsLook.com
Global Ebola Aid Increasing But Critics Say It's Late

Global Ebola Aid Increasing But Critics Say It's Late

Newsy (Sep. 21, 2014) More than 100 tons of medical supplies were sent to West Africa on Saturday, but aid workers say the global response is still sluggish. Video provided by Newsy
Powered by NewsLook.com
Sierra Leone in Lockdown to Control Ebola

Sierra Leone in Lockdown to Control Ebola

AP (Sep. 21, 2014) Sierra Leone residents remained in lockdown on Saturday as part of a massive effort to confine millions of people to their homes in a bid to stem the biggest Ebola outbreak in history. (Sept. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins